Adjudera

Awarded

FN Motol DNS – Okrelizumab

Track this recordFree account — get alerted when a contract here runs out.
Buyer
Fakultní nemocnice v Motole
Winners
ROCHE s.r.o.
Contract value
CZK 555,917,960
Bids received
1
Published
18 Jul 2025
Awarded
6 May 2025
Contract start
6 May 2025
Contract end
7 May 2026estimated
Sector
Medical equipment and pharmaceuticals
Region
Hlavní město Praha
Source
Original notice on TED (475223-2025)

More awards from this buyer

AwardedBuyerWinnerContract valuePublished
FN Motol DNS – AtezolizumabFakultní nemocnice v MotoleROCHE s.r.o.CZK 47,770,24018 Jul 2025
FN Motol DNS – BortezomibFakultní nemocnice v MotolePROMEDICA PRAHA GROUP, a.s.CZK 502,47518 Jul 2025
FN Motol DNS – IvosidenibFakultní nemocnice v MotolePHOENIX lékárenský velkoobchod, s.r.o.CZK 15,925,44418 Jul 2025
FN Motol DNS – Klarithromycin - tablety a suspenzeFakultní nemocnice v MotolePHARMOS, a.s.CZK 254,04418 Jul 2025
FN Motol DNS – Klarithromycin - infuzeFakultní nemocnice v MotolePROMEDICA PRAHA GROUP, a.s.CZK 426,38418 Jul 2025
FN Motol DNS – FingolimodFakultní nemocnice v MotolePROMEDICA PRAHA GROUP, a.s.CZK 2,063,46618 Jul 2025